{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Adverse Late and Long-Term Treatment Effects in Adult Allogeneic Hematopoietic Stem Cell Transplant Survivors

Purpose of Activity

To provide information about the potential adverse late and long-term treatment-related effects of allogeneic hematopoietic stem cell transplantation.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. recognize the potential adverse late and longterm treatment-related effects of allogeneic hematopoietic stem cell transplantation.
  2. identify evaluation and management strategies for cardiovascular disease risk factors that can occur either independently or concurrently as part of the metabolic syndrome.
Price: $27.95

Credits:

  • ANCC 3.0 CH
  • DC - BON 3.0 CH
  • FL - BON 3.0 CH
  • GA - BON 3.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.







Test Code: AJN1115A
Published: Nov 2015
Expires: 9/3/2021
Passing Score: 13/18 (72%)
Authors: Kara Mosesso, MSN, RN, ANP-BC
Categories: Oncology
Specialties: Oncology